SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

C4 Therapeutics, Inc. CCCC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

C4 Therapeutics, Inc. (CCCC) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ARVN, CGEM, CYT, ELYM, EWTX, FHTX 等.

CCCC 的市值为 $239.37M, 而同行平均市值为 $1.54B. CCCC 显著小于其平均同行.

同行与相似公司 — CCCC

$10.97 -0.27% $704.54M

Cullinan Oncology, Inc.

$14.95 +4.18% $904.87M

Cyteir Therapeutics, Inc.

$3.02 -2.27% $108.71M

Eliem Therapeutics, Inc.

$5.11 -0.97% $342.68M

Edgewise Therapeutics, Inc.

$33.70 +1.63% $3.62B

Foghorn Therapeutics Inc.

$4.87 +0.41% $285.87M

Monte Rosa Therapeutics, Inc.

$18.23 +4.17% $1.19B

Century Therapeutics, Inc.

$2.59 +9.28% $224.21M

Kymera Therapeutics, Inc.

$89.00 -0.96% $7.27B

Mineralys Therapeutics, Inc.

$30.42 +11.35% $2.02B

Nurix Therapeutics, Inc.

$16.97 +4.11% $1.47B

Prelude Therapeutics Incorporated

$5.52 +25.45% $307.61M

其他人也在看

Revolution Medicines, Inc.

Kymera Therapeutics, Inc.

Edgewise Therapeutics, Inc.

Mineralys Therapeutics, Inc.

Nurix Therapeutics, Inc.

Monte Rosa Therapeutics, Inc.

Cullinan Oncology, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言